BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Facciorusso A. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art. World J Gastroenterol 2018; 24(2): 161-169 [PMID: 29375202 DOI: 10.3748/wjg.v24.i2.161]
URL: https://www.wjgnet.com/1948-5182/full/v24/i2/161.htm
Number Citing Articles
1
Marwa Ahmed Sakr, Khaled Abdel Hamid Mohamed, Ahmed Mohamed Hussein, Mohamed Hassan Fouad, Ahmed Samir Allam, Eslam Safwat. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapyEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00090-y
2
Chuangen Guo, Cheng Wang, Jingfeng Zhang, Xiao Chen. <p>Treatment for Liver Tumor Using Combined Transarterial Embolization and Interaarterial Transfecting HIF-1α shRNA in a Rabbit VX2 Model</p>OncoTargets and Therapy 2020; : 8511 doi: 10.2147/OTT.S262434
3
Murtuza Razi, Gu Jianping, He Xu, Mohammed Jameeluddin Ahmed. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinomaJournal of Interventional Medicine 2021; 4(1): 11 doi: 10.1016/j.jimed.2020.10.006
4
Yan Zhang, Mei-Wu Zhang, Xiao-Xiang Fan, Da-Feng Mao, Quan-Hua Ding, Lu-Hui Zhuang, Shu-Yi Lv. Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinomaWorld Journal of Gastrointestinal Surgery 2020; 12(8): 355-368 doi: 10.4240/wjgs.v12.i8.355
5
Wenhua Wang, Lingchen Wang, Xinsheng Xie, Yehong Yan, Yue Li, Quqin Lu. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinomaBMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07692-6
6
Corinne E. Wessner, Colette M. Shaw, Maria Stanczak, Flemming Forsberg, Andrej Lyshchik, Allison Tan, John R. Eisenbrey. Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor VascularityUltrasound Quarterly 2020; 36(3): 218 doi: 10.1097/RUQ.0000000000000513
7
Sirish A. Kishore, Raazi Bajwa, David C. Madoff. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 UpdateCancers 2020; 12(4): 791 doi: 10.3390/cancers12040791
8
Seóna M. Rossi, Benedict K. Ryan, Helena M. Kelly. Evaluation of the activity of a chemo-ablative, thermoresponsive hydrogel in a murine xenograft model of lung cancerBritish Journal of Cancer 2020; 123(3): 369 doi: 10.1038/s41416-020-0904-9
9
Victoria Susanne Antonia Habbel, Martin Zeile, Gregor Alexander Stavrou, Frank Wacker, Roland Brüning, Karl-Jürgen Oldhafer, Thomas Rodt. Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinomaAbdominal Radiology 2019; 44(10): 3463 doi: 10.1007/s00261-019-02128-7
10
Amira Isaac, Sherif Mounir Mohamed, Osama Ashraf Ahmed, Ahmed Gamal Mohamed Hassan, Hany Samir Rasmy. Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatmentThe Egyptian Journal of Internal Medicine 2021; 33(1) doi: 10.1186/s43162-021-00078-5
11
Tarik Silk, Mikhail Silk, Jennifer Wu. Up to seven criteria in selection of systemic therapy for hepatocellular carcinomaWorld Journal of Gastroenterology 2022; 28(23): 2561-2568 doi: 10.3748/wjg.v28.i23.2561
12
Abheek Ghosh, Vikash Gupta, Abdullah Al Khalifah, Nabeel Mohsin Akhter. Transradial versus transfemoral arterial access in DEB-TACE for hepatocellular carcinomaJournal of Clinical Imaging Science 2022; 12: 38 doi: 10.25259/JCIS_47_2022
13
Lisa S. Parks, Patricia Little. Cirrhosis, Hepatocellular Carcinoma, and Locoregional TherapiesJournal of Radiology Nursing 2022; 41(2): 129 doi: 10.1016/j.jradnu.2022.01.005
14
Antonio Facciorusso, Irene Bargellini, Marina Cela, Ivan Cincione, Rodolfo Sacco. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score AnalysisCancers 2020; 12(4): 897 doi: 10.3390/cancers12040897
15
Chuzhi Shang, Mi Ke, Lin Liu, Cong Wang, Yufang Liu, Xin Zheng. Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT PathwayFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.868726
16
Baojian Li, Liaqat Ali. Prophylactic Use of Antibiotics for Postsurgical Infection in c-TACE and DEB-TACE High-Risk Patients: A Case-Control StudyJournal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/6203817
17
Masatoshi Kudo, Richard S. Finn, Manabu Morimoto, Kun-Ming Rau, Masafumi Ikeda, Chia-Jui Yen, Peter R. Galle, Josep M. Llovet, Bruno Daniele, Ho Yeong Lim, David W. McIlwain, Reigetsu Yoshikawa, Kenichi Nakamura, Kun Liang, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu. Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)Liver Cancer 2021; 10(5): 451 doi: 10.1159/000516605
18
Amar Karalli, Johan Teiler, Mojgan Haji, Elin Seth, Torkel B. Brismar, Staffan Wahlin, Rimma Axelsson, Per Stål. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life settingScandinavian Journal of Gastroenterology 2019; 54(7): 905 doi: 10.1080/00365521.2019.1632925
19
Arnold Man Nok Chui, Thomas Chung Cheung Yau, Tan To Cheung. An overview in management of hepatocellular carcinoma in Hong Kong using the Hong Kong Liver Cancer (HKLC) staging systemGlobal Health & Medicine 2020; 2(5): 312 doi: 10.35772/ghm.2020.01062
20
Degang Kong, Tao Jiang, Jian Liu, Xinyi Jiang, Bei Liu, Cheng Lou, Baobing Zhao, Steven L. Carroll, Gong Feng. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystalDrug Delivery 2020; 27(1): 1729 doi: 10.1080/10717544.2020.1856219
21
Li-Fang Bian, Xue-Hong Zhao, Bei-Lei Gao, Sheng Zhang, Guo-Mei Ge, Dong-Di Zhan, Ting-Ting Ye, Yan Zheng. Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancerWorld Journal of Gastroenterology 2020; 26(30): 4442-4452 doi: 10.3748/wjg.v26.i30.4442
22
Xu Gao, Zijian Chen, Zhengchang Chen, Xiaoya Liu, Yucheng Luo, Jingyu Xiao, Yanan Gao, Yutao Ma, Chuang Liu, Hwa Liang Leo, Hanry Yu, Qiongyu Guo. Visualization and Evaluation of Chemoembolization on a 3D Decellularized Organ ScaffoldACS Biomaterials Science & Engineering 2021; 7(12): 5642 doi: 10.1021/acsbiomaterials.1c01005
23
Stefan O. Schoenberg, Ulrike I. Attenberger, Stephen B. Solomon, Ralph Weissleder. Developing a Roadmap for Interventional OncologyThe Oncologist 2018; 23(10): 1162 doi: 10.1634/theoncologist.2017-0654
24
Aigerim Karina, Abderazak Benzina, Samal Tazhibayeva, Haiyan Fan, Levinus H. Koole. Polymer microparticles with a cavity designed for transarterial chemo‐embolization with crystalline drug formulationsJournal of Biomedical Materials Research Part B: Applied Biomaterials 2021; 109(3): 401 doi: 10.1002/jbm.b.34708
25
Felix Peisen, Michael Maurer, Ulrich Grosse, Konstantin Nikolaou, Roland Syha, Dominik Ketelsen, Christoph Artzner, Michael Bitzer, Marius Horger, Gerd Grözinger. Predictive performance of the mHAP-II score in a real-life western cohort with hepatocellular carcinoma following trans-arterial chemoembolisation with drug-eluting beads (DEB-TACE)European Radiology 2020; 30(7): 3782 doi: 10.1007/s00330-020-06734-8
26
Lin Li, Wenzhuo Zhao, Mengmeng Wang, Jie Hu, Enxin Wang, Yan Zhao, Lei Liu. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysisBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0849-0
27
Tianshi Lyu, Hang Yao, Jian Wang, Li Song, Xiaoqiang Tong, Yinghua Zou. Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombusClinics and Research in Hepatology and Gastroenterology 2022; 46(4): 101819 doi: 10.1016/j.clinre.2021.101819
28
Tommaso Cascella, Enrico Matteo Garanzini, Rodolfo Lanocita, Carlo Morosi, Federica Riva, Giorgio Greco, Carlo Sposito, Vincenzo Mazzaferro, Alfonso Marchianò, Carlo Spreafico. Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting BeadsCardioVascular and Interventional Radiology 2022; 45(1): 54 doi: 10.1007/s00270-021-02991-2
29
Jun Deng, Feng Wen. Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.824799
30
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancerWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
31
Anne Hulin, Jeanick Stocco, Mohamed Bouattour. Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular CarcinomaClinical Pharmacokinetics 2019; 58(8): 983 doi: 10.1007/s40262-019-00740-w
32
Begül Yağcı‐Küpeli, Tuğsan Ballı. Hepatoblastoma treated successfully with drug‐eluting bead transarterial chemoembolization: Outcome of seven‐year follow‐upPediatric Blood & Cancer 2021; 68(8) doi: 10.1002/pbc.29063
33
Jakub Fichtl, Vladislav Třeška, Tomáš Skalický, Václav Liška, Josef Vodička, Petr Duras, Jakub Šebek, Kristýna Procházková. Transarterial chemoembolization as a palliative treatment for primary and secondary liver cancers: the 2013-2017 cohort of the Pilsen University HospitalOnkologie 2021; 14(6): 287 doi: 10.36290/xon.2020.095
34
Gaofeng Sun, Tao Wang, Xiao Li, Danni Li, Ye Peng, Xiaoke Wang, Guorong Jia, Weiwei Su, Chao Cheng, Jian Yang, Changjing Zuo. Sub-Micrometer Au@PDA-125 I Particles as Theranostic Embolism Beads for Radiosensitization and SPECT/CT MonitoringAdvanced Healthcare Materials 2018; 7(16): 1800375 doi: 10.1002/adhm.201800375
35
K. Malagari, H. Moschouris, Th. Kiakidis, S. Harward, A. Kelekis, S. Vrakas, D. Koundouras, D. Filipiadis, G. Glantzounis, E. Emmanouil, A. Chatziioannou, V. Vergadis, I. Elefsiniotis, J. Koskinas, S. Dourakis, N. Kelekis. Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30–60 μm: Results from a Single-Centre Prospective Phase II TrialCardioVascular and Interventional Radiology 2019; 42(11): 1551 doi: 10.1007/s00270-019-02260-3
36
Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao, Changqing Li. Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort studyClinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101535 doi: 10.1016/j.clinre.2020.09.002
37
Cristiana Bergamini, Stefano Cavalieri, Tommaso Cascella, Rodolfo Lanocita, Salvatore Alfieri, Carlo Resteghini, Francesca Platini, Ester Orlandi, Laura Deborah Locati, Alfonso Marchianò, Lisa Licitra. Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case seriesTumori Journal 2020; : 030089162095284 doi: 10.1177/0300891620952844
38
Takuji Torimura, Hideki Iwamoto. Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospectsClinical and Molecular Hepatology 2021; 27(2): 236 doi: 10.3350/cmh.2020.0204
39
Chia-Ying Lin, Yi-Sheng Liu, Kuang-Tse Pan, Chia-Bang Chen, Chein-Fu Hung, Chen-Te Chou. The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatmentScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91021-9
40
Kensuke Yamamura, Toru Beppu, Nobutaka Sato, Eri Oda, Koichi Kinoshita, Hideaki Yuki, Toshihiko Motohara, Hideaki Miyamoto, Tsutomu Oda, Shinichi Akahoshi. Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case reportClinical Journal of Gastroenterology 2021; 14(1): 251 doi: 10.1007/s12328-020-01286-2
41
Xiaojun Wang, Huiyun Zhang, Liangfen Zhou, Hui Ou, Hengyu Liu. Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Locally Advanced Non-small Cell Lung CancerCancer Biotherapy and Radiopharmaceuticals 2020;  doi: 10.1089/cbr.2020.4301
42
Lorena Baboci, Sara Capolla, Federica Di Cintio, Federico Colombo, Prisca Mauro, Michele Dal Bo, Monica Argenziano, Roberta Cavalli, Giuseppe Toffoli, Paolo Macor. The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic TargetJournal of Oncology 2020; 2020: 1 doi: 10.1155/2020/4638192
43
Monica Mossenta, Davide Busato, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative TherapiesInternational Journal of Molecular Sciences 2022; 23(17): 10038 doi: 10.3390/ijms231710038
44
Kai-Cai Liu, Wei-Fu lv, Dong Lu, Chang-Long Hou, Jun Xie, Yu-He Lu, Qi-Sheng Cao, Yu-Lin Tan, Ying-Zhan Zhang, Jie Liu. Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular CarcinomaCancer Management and Research 2021; : 7973 doi: 10.2147/CMAR.S332571
45
Andrea Chierici, Andrew Ofosu, Ivan Cincione, Rodolfo Sacco, Christian Cotsoglou, Antonio Facciorusso. Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma?Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 205 doi: 10.1016/j.hbpd.2020.12.005
46
Jan Vosshenrich, Christoph J. Zech, Tobias Heye, Tuyana Boldanova, Geoffrey Fucile, Stefan Wieland, Markus H. Heim, Daniel T. Boll. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree modelsEuropean Radiology 2021; 31(6): 4367 doi: 10.1007/s00330-020-07511-3
47
Jiao Zhang, Guo‐an Feng, Yuliang Li, Wujie Wang. Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancerAsia-Pacific Journal of Clinical Oncology 2022; 18(4): 388 doi: 10.1111/ajco.13660
48
Jose Urbano, J. Javier Echevarria-Uraga, J. Jose Ciampi-Dopazo, Juan A. Sánchez-Corral, Jorge Cobos Alonso, Ane Anton-Ladislao, Borja Peña-Baranda, Veronica Nacarino-Mejias, Rocío González-Costero, J. Joaquín Muñoz Ruiz-Canela, Julian Pérez-Cuesta, Carlos Lanciego, Miguel Angel de Gregorio. Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinomaEuropean Journal of Radiology 2020; 126: 108966 doi: 10.1016/j.ejrad.2020.108966
49
Han Wang, Hua Yu, You-Wen Qian, Zhen-Ying Cao, Meng-Chao Wu, Wen-Ming Cong. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2021; 20(3): 232 doi: 10.1016/j.hbpd.2020.12.018
50
Yi-Sheng Liu, Pi-Yi Chang, Po-Chin Liang, Ming-Ching Ou, Jen-I Hwang, Chien-Hung Chen. Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)Journal of Hepatocellular Carcinoma 2022; : 811 doi: 10.2147/JHC.S374555
51
Alberta Cappelli, Giuliano Peta, Rita Golfieri. Imaging of the Liver and Intra-hepatic Biliary TractMedical Radiology 2021; : 283 doi: 10.1007/978-3-030-39021-1_13
52
Haris Muhammad, Aniqa Tehreem, Peng-Sheng Ting, Merve Gurakar, Sean Young Li, Cem Simsek, Saleh A. Alqahtani, Amy K. Kim, Ruhail Kohli, Ahmet Gurakar. Hepatocellular Carcinoma and the Role of Liver Transplantation: A ReviewJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00125
53
Antonio Facciorusso, Rosa Paolillo, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Saurabh Chandan, Antonio Ambrosi, Irene Bargellini, Matteo Renzulli, Rodolfo Sacco. Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysisDigestive and Liver Disease 2022; 54(3): 316 doi: 10.1016/j.dld.2021.06.003
54
Alice Hagan, Marcus Caine, Cara Press, Wendy M. Macfarlane, Gary Phillips, Andrew W. Lloyd, Peter Czuczman, Hugh Kilpatrick, Zainab Bascal, Yiqing Tang, Pedro Garcia, Andrew L. Lewis. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methodsEuropean Journal of Pharmaceutical Sciences 2019; 136: 104943 doi: 10.1016/j.ejps.2019.05.021
55
Seona M. Rossi, Timothy Murray, Liam McDonough, Helena Kelly. Loco-regional drug delivery in oncology: current clinical applications and future translational opportunitiesExpert Opinion on Drug Delivery 2021; 18(5): 607 doi: 10.1080/17425247.2021.1856074
56
Yanqiao Ren, Yusheng Guo, Lei Chen, Tao Sun, Weihua Zhang, Bo Sun, Licheng Zhu, Fu Xiong, Chuansheng Zheng. Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular CarcinomaCancer Control 2022; 29: 107327482210768 doi: 10.1177/10732748221076806
57
Antonio Facciorusso, Mohamed A. Abd El Aziz, Nicola Tartaglia, Daryl Ramai, Babu P. Mohan, Christian Cotsoglou, Sara Pusceddu, Luca Giacomelli, Antonio Ambrosi, Rodolfo Sacco. Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled TrialsCancers 2020; 12(12): 3796 doi: 10.3390/cancers12123796
58
Song Yi Lee, Jin Woo Choi, Jae-Young Lee, Dae-Duk Kim, Hyo-Cheol Kim, Hyun-Jong Cho. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumorDrug Delivery 2018; 25(1): 1472 doi: 10.1080/10717544.2018.1480673
59
Katerina Malagari, Alban Denys, Marta Burrel, Maria Reig, Mercé Brunet, Rafael Duran, Theodoros Kiakidis, Hippokratis Moschouris, Marco Sanduzzi-Zamparelli, Jordi Bruix. Polyethylene Glycol Drug-Eluting Embolic Microspheres Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma: Feasibility, Safety, and Pharmacokinetic StudyJournal of Vascular and Interventional Radiology 2022; 33(7): 752 doi: 10.1016/j.jvir.2021.11.019
60
Nihal Mostafa, Ahmed Salem, Somaya Z. Mansour, Sawsan M. El-Sonbaty, Fatma S. M. Moawed, Eman I. Kandil. Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical ChallengesTechnology in Cancer Research & Treatment 2022; 21: 153303382210853 doi: 10.1177/15330338221085376
61
Hua Xiang, Lin Long, Yuanhui Yao, Zhiyong Fang, Zhiming Zhang, Yongjin Zhang. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2019; 18: 153303381983075 doi: 10.1177/1533033819830751
62
David S. Monahan, Talal Almas, Robert Wyile, Faisal H. Cheema, Garry P. Duffy, Aamir Hameed. Towards the use of localised delivery strategies to counteract cancer therapy–induced cardiotoxicitiesDrug Delivery and Translational Research 2021; 11(5): 1924 doi: 10.1007/s13346-020-00885-3
63
Zhen Li, Du Xiao, Xin Li, Pengchao Zhan, Jiaxiang Wang, Henghui Zhang. Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNAEuropean Journal of Gastroenterology & Hepatology 2019; 31(7): 885 doi: 10.1097/MEG.0000000000001373
64
Alexander Gross, Thomas Albrecht. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and EfficacyCardioVascular and Interventional Radiology 2020; 43(3): 402 doi: 10.1007/s00270-019-02364-w
65
H. Perfahl, H. V. Jain, T. Joshi, M. Horger, N. Malek, M. Bitzer, M. Reuss. Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65012-1
66
Isabelle Mohr, Marie Vogeler, Jan Pfeiffenberger, Simon David Sprengel, Miriam Klauss, Boris Radeleff, Andreas Teufel, De-Hua Chang, Christoph Springfeld, Thomas Longerich, Uta Merle, Arianeb Mehrabi, Karl Heinz Weiss, Markus Mieth. Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2022; 148(11): 3163 doi: 10.1007/s00432-021-03900-3